Close
ACHEMA MIDDLE EAST 2026

Pfizer And Touchlight Enter Into A Patent Collaboration

Pfizer and another pharmaceutical major, Touchlight, have come to a deal on a significant non-exclusive patent licence. Touchlight is a firm that focuses on...

AstraZeneca, GSK Weathered Q2 Storm, But Roche Stock Plunged

The standard response to any poor performance is to blame the supply chain, which has almost attained the status of a joke. However, it...

Deloitte Believes Mature R&D Firms Reap Enterprise Value

According to the third Real-World Evidence (RWE) benchmarking survey published in June 2022 by Deloitte, there is a segmentation of outcomes between businesses with...

Sanofi Sets Up Fund To Enable Firms In Low-Income Countries

The Paris-based pharmaceutical company is setting up a fund to assist companies who want to provide healthcare solutions in neglected areas. The objective is...

Singapore Authorises New Ovarian Cancer Treatment By GSK

The oral, once-daily Zejula (niraparib) tablet, a first-line and recurrent upkeep care for women with advanced epithelial high-grade ovarian, fallopian tube, or primary peritoneal...

Abbott India Affirms That The Medicines Are Not Their Own

Abbott informed yesterday, July 3rd, that there are several ways to tell if a customer's pack of Thyronorm is authentic or fake. The label...

Global Biopharmaceutical Bioseparation Market Eyeing $20bn

Recent market analysis predicts that the international market for biopharmaceutical bioseparation systems, which is expected to be worth $13 billion in 2022, will increase...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...